Who Paid My Doc
Matthew Malone
Geriatric Psychiatry Oro Valley, AZ Doctor of Osteopathy
NPI 1912952136 CMS profile 358971
1551 E Tangerine Rd, Oro Valley, AZ 85755
General payments
$1,661
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$418,727
Through program year 2024, Matthew Malone of Oro Valley, AZ is reported in the CMS Open Payments database as having received $1,661 across 7 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $418,727 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 78th percentile of Geriatric Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $1,552 | 4 | |
| 2021 | General | $64 | 1 | |
| 2020 | General | $29 | 1 | |
| 2019 | General | $16 | 1 |
Beside peers
- Matthew Malone
- Geriatric Psychiatry median
- Middle half of Geriatric Psychiatry
- National median
In program year 2025, general payments to Matthew Malone were reported at $0. Among 188 Geriatric Psychiatry profiles paid that year, the median was $125 and the middle half received between $52 and $515.
Show as a table
| Year | Matthew Malone | Geriatric Psychiatry median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $16 | $151 | $47–$484 | $163 |
| 2020 | $29 | $112 | $30–$410 | $114 |
| 2021 | $64 | $122 | $35–$550 | $132 |
| 2022 | $0 | $133 | $54–$557 | $149 |
| 2023 | $0 | $138 | $61–$485 | $160 |
| 2024 | $1,552 | $127 | $51–$572 | $164 |
| 2025 | $0 | $125 | $52–$515 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 18 drugsPart D claims
514
Drug cost
$13,849
Branded share of claims
18.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Thiothixene | Generic | 11 | $2,460 | |
| Memantine Hcl Er Memantine Hcl | Brand | 17 | $2,047 | |
| Donepezil Hcl | Generic | 123 | $1,864 | |
| Memantine Hcl | Generic | 42 | $1,447 | |
| Mirtazapine | Generic | 29 | $1,047 | |
| Venlafaxine Hcl Er Venlafaxine Hcl | Brand | 37 | $852 | |
| Bupropion Xl Bupropion Hcl | Brand | 26 | $819 | |
| Duloxetine Hcl | Generic | 17 | $768 | |
| Quetiapine Fumarate | Generic | 23 | $723 | |
| Sertraline Hcl | Generic | 29 | $304 |
The 10 drugs with the highest cost, of 18 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 10 billing codesPaid by Medicare
$31,359
Medicare patients
84
Services billed
337
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Alzheimer's or dementia | 60% | |
| High blood pressure | 51% | |
| Depression | 44% | |
| Arthritis | 43% | |
| Ischemic heart disease | 27% | |
| Chronic kidney disease | 21% | |
| Diabetes | 18% | |
| Osteoporosis | 18% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
7 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Geriatric Psychiatry in Arizona
Related records
Geriatric Psychiatry in Arizona
Practitioners in the same specialty and state, ranked by reported value.
All Geriatric Psychiatry
Everyone recorded under this specialty, nationwide.
Doctors in Arizona
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.